KinderCare: Buy-rated Growth Stock

This is a VNS news story, published by Yahoo Finance, that relates primarily to David Roman news.

VNS news

For more VNS news, you can click here:

more VNS news

David Roman news

For more David Roman news, you can click here:

more David Roman news

stocks trading & speculation news

For more stocks trading & speculation news, you can click here:

more stocks trading & speculation news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about

KinderCare Learning Companies

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest KinderCare news, early childhood education centers news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

early childhood education company

TipRanks

•

Goldman Sachs Says Improving Growth Could Propel These 2 Stocks Higher

Summary

Nutrition label

78% Informative

Goldman Sachs analysts are evaluating individual stocks, pinpointing those best positioned to thrive in a growth-oriented market.

KinderCare Learning Companies (KLC) is a for-profit early childhood education company.

LivaNova (LIVN) is best known to the public for its VNS (vagus nerve) products, the treatment of epilepsy.

LivaNova ’s VNS implant can be used to send mild electrical stimulation to the brain through the vagus nerve which connects to areas of the brain that control mood.

VNS device treatments have been used in well over 100,000 patients, including over 30,000 children.

Goldman analyst David Roman puts a Buy rating on LIVN stock, and he complements that with a price target of $ 65 , suggesting a one-year upside of 25.5% .

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful